Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Trey Thoelcke | Mar 10, 2016 at 7:55 AM EST

The 5 Most Shorted NYSE Stocks: Chesapeake Energy Leads the Trend

Most of the stocks traded on the New York Stock Exchange with the greatest number of shares short saw their…

Jon C. Ogg | Mar 8, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony,…

Lee Jackson | Mar 3, 2016 at 8:35 AM EST

Dogs of the Dow on Fire in 2016: 4 to Buy With Yields of 4% or More

So far this year, based on changes in yields, the Dogs of the Dow are doing much better, as their…

Paul Ausick | Feb 29, 2016 at 4:01 PM EST

The 4 Stocks That Sank the DJIA on Monday

February 29, 2016: Markets opened lower on Monday before rising to intra-day highs at around noon, and then dipping to…

Lee Jackson | Feb 29, 2016 at 10:45 AM EST

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these…

Paul Ausick | Feb 26, 2016 at 4:01 PM EST

The 4 Stocks That Weighed on the DJIA Friday

February 26, 2016: Markets opened higher on Friday on rising oil prices in Asia and Europe which turned into lower…

Lee Jackson | Feb 26, 2016 at 8:20 AM EST

3 Highest Yielding Merrill Lynch US 1 Portfolio Stocks to Buy Now

For the long haul, these three stock should provide a much better avenue for total return and continue to increase…

Chris Lange | Feb 25, 2016 at 8:10 AM EST

Short Sellers Increase Bets in Major Pharma

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Trey Thoelcke | Feb 25, 2016 at 6:15 AM EST

The 5 Most Shorted NYSE Stocks: Chesapeake Bucks the Trend

The most shorted stock traded on the New York Stock Exchange — Chesapeake Energy — bucked the short interest trend…

Chris Lange | Feb 24, 2016 at 12:45 PM EST

Pfizer Sinks Despite Winning FDA Approval

Pfizer has announced that the FDA approved Xeljanz XR (tofacitinib citrate) extended-release tablets for the once-daily treatment of moderate to…

Lee Jackson | Feb 24, 2016 at 9:50 AM EST

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

These stocks make good sense for long-term patient investors that have a growth and income total return bias in their…

Lee Jackson | Feb 22, 2016 at 11:40 AM EST

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend…

Lee Jackson | Feb 19, 2016 at 8:20 AM EST

4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential

For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.

Paul Ausick | Feb 16, 2016 at 8:55 AM EST

Pfizer Settles Medicaid Case for $785 Million

Pfizer has announced that it had settled outstanding claims for a total of more than $784 million related to calculated…

1 … 50 51 52 53 54 … 98

Pfizer : PFE

All Pfizer Articles

Major Pharma Short Interest Takes a Small Step Back

The 5 Most Shorted NYSE Stocks: Chesapeake Energy Leads the Trend

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

Dogs of the Dow on Fire in 2016: 4 to Buy With Yields of 4% or More

The 4 Stocks That Sank the DJIA on Monday

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

The 4 Stocks That Weighed on the DJIA Friday

3 Highest Yielding Merrill Lynch US 1 Portfolio Stocks to Buy Now

Short Sellers Increase Bets in Major Pharma

The 5 Most Shorted NYSE Stocks: Chesapeake Bucks the Trend

Pfizer Sinks Despite Winning FDA Approval

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential

Pfizer Settles Medicaid Case for $785 Million

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Pfizer : PFE

All Pfizer Articles

Major Pharma Short Interest Takes a Small Step Back

The 5 Most Shorted NYSE Stocks: Chesapeake Energy Leads the Trend

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

Dogs of the Dow on Fire in 2016: 4 to Buy With Yields of 4% or More

The 4 Stocks That Sank the DJIA on Monday

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

The 4 Stocks That Weighed on the DJIA Friday

3 Highest Yielding Merrill Lynch US 1 Portfolio Stocks to Buy Now

Short Sellers Increase Bets in Major Pharma

The 5 Most Shorted NYSE Stocks: Chesapeake Bucks the Trend

Pfizer Sinks Despite Winning FDA Approval

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential

Pfizer Settles Medicaid Case for $785 Million

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up